Episode
Ep 178: Metabolic Effects of IA Corticosteroids with Dr. Allen Page
- Podcast
- Disease Du Jour
- Published
- Mar 19, 2026
- Duration seconds
- 1848
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/disease-du-jour-15968/episodes/ep-178-metabolic-effects-of-ia-corticosteroids-with-dr-allen-page/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/disease-du-jour-15968/ep-178-metabolic-effects-of-ia-corticosteroids-with-dr-allen-page.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this episode, Allen Page, DVM, PhD, joined us to discuss some of his research on the metabolic effects of various intra-articular corticosteroids, as well as how ertugliflozin may influence horses’ metabolic responses to these treatments. Page spoke about how differences among corticosteroids can inform veterinarians’ choices when selecting intra-articular agents, key considerations when using SGLT2 inhibitors in horses that require joint injections, the limitations of the current research, and more. This episode of Disease Du Jour is brought to you by Equithrive. GUESTS AND LINKS - EPISODE 178: Host: Carly Sisson (Digital Content Manager) of EquiManagement | Email Carly ([email protected]) Guest: Allen Page, DVM, PhD Podcast Website: Disease Du Jour This episode of Disease Du Jour podcast is brought to you by Equithrive . Connect with the Host: Carly Sisson (Digital Content Manager) of EquiManagement | Email Carly ([email protected])